The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy Subjects

NCT04229433 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombus

Interventions

DRUG: SHR2285 tablet
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.